41 Preliminary results of a randomized comparative phase III trial of topotecan (T) versus CAV as second-line therapy of small cell lung cancer (SCLC)
- 1 August 1997
- journal article
- abstracts
- Published by Elsevier in Lung Cancer
- Vol. 18, 13-14
- https://doi.org/10.1016/s0169-5002(97)89320-8
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: